Teva Introduces First Generic Effexor XR(R) Capsules In The United States; Awarded 180-Day Period Of Marketing Exclusivity

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced that it has commenced commercial launch of Venlafaxine HCl ER Capsules, the Company's generic version of Wyeth's antidepressant Effexor XR®. The brand product had annual sales of approximately $2.75 billion in the United States, based on IMS sales data...

Read the original post at Psychology / Psychiatry News From Medical News Today ...

Share your thoughts.